Preclinical characterization and antitumor efficacy of DS-6051b, a novel, orally available small molecule tyrosine kinase inhibitor of ROS1 and NTRKsM. Kiga, S. Iwasaki, N. Togashi,Y. Takeda,Y. Kagoshima, K. Kanai, Y. Kamai,Y. Tominaga,T. IsoyamaEuropean Journal of Cancer（2016）引用 6|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
